Skip to main content

Benitec Biopharma Inc.

BNTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001808898

No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Benitec Biopharma Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of BNTC: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders88386+1
Shares32.5M2.88M33.1M+3.53M (+11.9%)
Value$346.0M$30.7M$443.3M+$128.0M (+40.6%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Benitec Biopharma Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to BNTC in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC2,478,547$33.1M0.01%
AQR Capital Management LLC22,481$300.8K0.00%
Price T Rowe Associates Inc18,528$248.0K0.00%
Martingale Asset Management L P16,150$216.1K0.01%
Invesco Ltd.10,985$147.0K0.00%
Nisa Investment Advisors, LLC2,900$38.8K0.00%
SRS Capital Advisors, Inc.249$3.33K0.00%
Cornerstone Planning Group LLC46$5260.00%
Farther Finance Advisors, LLC20$2630.00%
Clearstead Advisors, LLC4$540.00%
SJS Investment Consulting Inc.2$270.00%

Sold out (10)

Institutions that held Benitec Biopharma Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of BNTC in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Marshall Wace, LLP71,832$765.0K
Empery Asset Management, LP30,440$324.2K
Brevan Howard Capital Management LP16,610$176.9K
Susquehanna International Group, LLP11,908$126.8K
Creative Planning11,586$123.4K
Quadrant Capital Group LLC173$1.84K
Signaturefd, LLC170$1.81K
MAI Capital Management5$54
Northwestern Mutual Wealth Management Co2$21
IFP Advisors, Inc1$11

Not filed for Q2 2026 yet (3)

Institutions that held Benitec Biopharma Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BNTC in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC2,876,380$30.7M
CWM, LLC68$724
Sunbelt Securities, Inc.4$43